Literature DB >> 30900474

Sexuality in premature ovarian insufficiency.

R E Nappi1, L Cucinella1, E Martini1, M Rossi1, L Tiranini1, S Martella1, D Bosoni1, C Cassani1.   

Abstract

Sexuality in women with spontaneous premature ovarian insufficiency (POI) deserves attention because of the young age and the distressing impact of such a life-changing diagnosis. Biomedical and psychosocial factors work in concert to determine significant changes of sexual function. Early hormonal deprivation gives origin to symptomatic vulvovaginal atrophy and contributes to hypoactive sexual desire disorder modulating central and peripheral circuitries, which regulate sexual response. Emotional and cognitive adjustment to the short-term and long-term consequences of POI may further determine negative attitudes toward sexuality. It is essential to counsel POI women on every aspect of their life, from menopausal symptoms to fertility concerns, from health risks to potential therapeutic solutions. The biopsychosocial perspective is the best approach to manage sexual symptoms, including tailored hormone therapy and focused counseling. Pharmacotherapies specifically investigated in spontaneous POI conditions are lacking and clinical judgment has to guide the choice of treatment, which must be continued at least until the average age at natural menopause according to the most recent guidelines. Further studies are needed to better characterize POI women and to understand the effective role of novel therapeutic strategies, including androgens and cognitive-behavioral and sexual interventions.

Entities:  

Keywords:  Premature ovarian insufficiency; androgens; counseling; estrogens; female sexual dysfunction; female sexual function; psychosexual therapy

Mesh:

Year:  2019        PMID: 30900474     DOI: 10.1080/13697137.2019.1575356

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  5 in total

Review 1.  Sexual problems in patients with hematological diseases: a systematic literature review.

Authors:  Corien Eeltink; Alaa Embaby; Luca Incrocci; Johannes C F Ket; Sarah J Liptrott; Irma Verdonck-de Leeuw; Sonja Zweegman
Journal:  Support Care Cancer       Date:  2022-01-21       Impact factor: 3.603

2.  International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.

Authors:  Sharon J Parish; James A Simon; Susan R Davis; Annamaria Giraldi; Irwin Goldstein; Sue W Goldstein; Noel N Kim; Sheryl A Kingsberg; Abraham Morgentaler; Rossella E Nappi; Kwangsung Park; Cynthia A Stuenkel; Abdulmaged M Traish; Linda Vignozzi
Journal:  J Womens Health (Larchmt)       Date:  2021-04-01       Impact factor: 2.681

3.  Melatonin protects against ovarian damage by inhibiting autophagy in granulosa cells in rats.

Authors:  Yan Liu; Xiaohe Zhu; Chunli Wu; Yan Lang; Wenjie Zhao; Yanmin Li
Journal:  Clinics (Sao Paulo)       Date:  2022-10-01       Impact factor: 2.898

Review 4.  Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women.

Authors:  Rossella E Nappi; Ellis Martini; Laura Cucinella; Silvia Martella; Lara Tiranini; Alessandra Inzoli; Emanuela Brambilla; David Bosoni; Chiara Cassani; Barbara Gardella
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-21       Impact factor: 5.555

5.  A comparison of the efficacy and safety of complementary and alternative therapies for premature ovarian insufficiency: A protocol for network meta-analysis.

Authors:  Lei Zhang; Honglin Li; Jianwei Zhang; Xinliang Kong; Zhijuan Wu; Shuangqian Dong; Xiuyun Qin
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.